ATTACHMENT G1:
PHYSICIAN RECRUITMENT MATERIALS
hysician Lead Letter
Date
Physician Name
Address 1
Address 2
City, State, Zip Code
Dear Dr. Name:
The Centers for Disease Control and Prevention (CDC) have asked RTI International (RTI), a non-profit health research organization, to contact primary care physicians to learn about their opinions and practices related to cancer screening. RTI is a research institute that specializes in research on health services and public health.
Using standard sampling techniques we have selected primary care physicians around the country to participate in telephone group discussions about cancer screening. Your name was selected and we are asking you to help with this important study.
Your input is critical to making this study valid, significant and influential. CDC is seeking a better understanding of the knowledge, attitudes, and practices of primary care physicians related to cancer screening. In particular, they hope to better understand how physicians use existing guidelines for cancer screening and how useful they are to everyday practice. In addition, CDC is interested in what physicians tell patients about testing for certain cancers when currently available screening tests are limited.
Your opinions will be compiled with those of the other physician participants and will be provided to the CDC so that they are able to better understand those factors that physicians deal with on a daily basis that affect screening policies and decisions.
The results of this assessment will be used to improve efforts in cancer prevention and control. Of course, your confidentiality will be protected, and your name will not be associated with any written report. Transcripts will not have identifiers, and contact information will be locked in filing cabinets with restricted access. At the end of the study, all tapes recorded during group discussions will be destroyed.
Your role will be to participate in a group discussion with about five other primary care physicians. We will convene this meeting via a teleconference call and connect everyone using a home or office telephone number. Risks associated with your participation are minimal but may involve a loss of confidentiality, should you know anyone participating. You will not benefit personally by participating. We realize that you seldom have extra time in your busy schedule. To help reduce this burden, we will provide you with $175 to compensate you for your time.
We have scheduled six possible dates and times for these important group discussions:
1
2
3
4
5
6
Please complete the enclosed response form if you are interested and available to participate in one or more of these groups. We will then send you a confirmation on the group for which you are scheduled. Since time is critical, please send us your completed response form and consent form as soon as possible and no later than XX-XX-XX. You can fax them to the number listed on the form using the enclosed Fax Cover Sheet, or mail them to us in the postage-paid envelope, or both. We hope you will help us with this important study.
If you have any logistical questions, you may contact Cindy Soloe, the RTI Study Coordinator, at [email protected] or 919-316-3363. If you have questions about the purpose of the study, you may call me at 770-488-2415.
Sincerely,
Amy DeGroff, MPH
Senior Scientist
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
Who is sponsoring this study? The Centers for Disease Control and Prevention (CDC)
What is the purpose of this study? CDC is seeking a better understanding of the knowledge, attitudes, and practices of primary care physicians related to cancer screening. In particular, they hope to better understand how physicians use existing guidelines for cancer screening and how useful they are to everyday practice.
What is being asked of me? If you choose to take part in this study, you will be scheduled to participate in a one time 75-minute group telephone discussion with five to seven other primary care physicians.
How was my name selected? Using standard sampling techniques, we selected a subset of primary care physicians from the American Medical Association Masterfile. Your name was among those selected.
What does participation involve? Participation will involve a one time 75-minute group telephone discussion with five to seven other primary care physicians.
Will I be compensated for my participation? We will provide you with $175 to compensate your for your time in participating.
How do I express interest in participating? To express interest, please complete and return the enclosed consent form and response/screener form no later than XX/XX/XXXX. You may return these forms by fax using the enclosed Fax Cover Sheet, or mail them to us in the enclosed postage-paid envelope, or both.
How will information from this study be used? Respondent opinions will be compiled and will be provided to CDC so that they can better understand those factors that physicians deal with on a daily basis that affect cancer screening policies and decisions. The results of this assessment will be used to improve efforts in cancer prevention and control.
How will my confidentiality be protected? Respondent names will not be associated with any written report. Transcripts will not have identifiers, and contact information will be locked in filing cabinets with restricted access. At the end of the study, all tapes recorded during group discussions will be destroyed.
Who can I contact if I have questions? If you have any logistical questions, you may contact Cindy Soloe, MPH, RTI Study Coordinator, at [email protected] or 919-316-3363. If you have questions about the purpose of the study, you may contact Amy DeGroff, MPH, CDC Project Officer, at (770) 488-2415.
Fax
l Comments:
Completed Response Form and Consent Form for the CDC Physician Cancer Screening Discussion Group follow
Date
Physician Name
Address 1
Address 2
City, State, Zip Code
Dear Dr. Name:
Thank you for volunteering to participate in a group discussion on cancer screening opinions and practices. The thoughts and experiences of primary care physicians are crucial to this study. We would like to confirm you participation in the group discussion scheduled for:
Date Time
As indicated in the invitation letter, your role will be to participate in a group discussion with about five to seven other primary care physicians. We will convene this meeting via a teleconference call and connect everyone using a home or office telephone number. We will be calling you at the following telephone number:
Telephone Number to reach physician for FG
If this number is incorrect, or if you would like us to reach you at another telephone number, please contact Cindy Soloe at [email protected] or 919-316-3363. Ms. Soloe is also available to answer any questions about the study, or you may call me at 770-488-2415. Thank you very much for your interest in helping with this important study.
Sincerely,
Amy DeGroff, MPH
Senior Scientist
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
Date
Physician Name
Address 1
Address 2
City, State, Zip Code
Dear Dr. Name:
Thank you for volunteering to participate in a group discussion on cancer screening opinions and practices. The thoughts and experiences of primary care physicians are crucial to this study. We had a very strong response from those we contacted and the sessions have been filled. Thus, we are unable to schedule you for the sessions you selected.
We would like to keep your name as an alternate participant since we may have a cancellation. If we do have someone cancel, we will contact you to see whether you are still available to participate. We will try to give you as much notice as possible.
Should you have any questions about the study, please contact Cindy Soloe at [email protected] or 919-316-3363 or you may call me at 770-488-2415. Thank you very much for your interest in helping with this important study.
Sincerely,
Amy DeGroff, MPH
Senior Scientist
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
| File Type | application/msword |
| File Title | Attachment D: Patient Informed Consent Form |
| Author | Christina Lynch |
| Last Modified By | arp5 |
| File Modified | 2008-07-11 |
| File Created | 2008-07-11 |